The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
Inserm · Université Côte d'Azur
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
852
total citations
- FWCI
- 18.53
- Percentile
- 100%
- References
- 42
Citations per year
Authors
9Topics & keywords
Topics
Keywords
- Metformin
- DU145
- LNCaP
- AMPK
- Biology
- Cyclin D1
- Cell growth
- Cancer research
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.